** Shares of vaccine maker Moderna MRNA.O rise 9.2% to $33.19 premarket
** CEO Stephane Bancel has bought ~160,000 MRNA shares at roughly $31/shr, SEC filing showed late Tuesday
** MRNA shares have fallen 39.1% since mid-January, when co cut 2025 sales forecast by $1 bln
** Co has ~385 million outstanding shares, as of February 14
** Stock fell 68.3% in past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。